393 related articles for article (PubMed ID: 15994290)
21. Regulation of the human leukemia inhibitory factor gene by ETS transcription factors.
Bamberger AM; Jenatschke S; Schulte HM; Ellebrecht I; Beil FU; Bamberger CM
Neuroimmunomodulation; 2004; 11(1):10-9. PubMed ID: 14557674
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional regulation of erythropoiesis. Fine tuning of combinatorial multi-domain elements.
Perry C; Soreq H
Eur J Biochem; 2002 Aug; 269(15):3607-18. PubMed ID: 12153557
[TBL] [Abstract][Full Text] [Related]
23. The paralogous hematopoietic regulators Lyl1 and Scl are coregulated by Ets and GATA factors, but Lyl1 cannot rescue the early Scl-/- phenotype.
Chan WY; Follows GA; Lacaud G; Pimanda JE; Landry JR; Kinston S; Knezevic K; Piltz S; Donaldson IJ; Gambardella L; Sablitzky F; Green AR; Kouskoff V; Göttgens B
Blood; 2007 Mar; 109(5):1908-16. PubMed ID: 17053063
[TBL] [Abstract][Full Text] [Related]
24. Fli-1b is generated by usage of differential splicing and alternative promoter.
Dhulipala PD; Lee L; Rao VN; Reddy ES
Oncogene; 1998 Sep; 17(9):1149-57. PubMed ID: 9764825
[TBL] [Abstract][Full Text] [Related]
25. A single amino-acid substitution in the Ets domain alters core DNA binding specificity of Ets1 to that of the related transcription factors Elf1 and E74.
Bosselut R; Levin J; Adjadj E; Ghysdael J
Nucleic Acids Res; 1993 Nov; 21(22):5184-91. PubMed ID: 8255775
[TBL] [Abstract][Full Text] [Related]
26. PU.1 binding to ets motifs within the equine infectious anemia virus long terminal repeat (LTR) enhancer: regulation of LTR activity and virus replication in macrophages.
Hines R; Sorensen BR; Shea MA; Maury W
J Virol; 2004 Apr; 78(7):3407-18. PubMed ID: 15016863
[TBL] [Abstract][Full Text] [Related]
27. Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells.
Deleuze V; El-Hajj R; Chalhoub E; Dohet C; Pinet V; Couttet P; Mathieu D
PLoS One; 2012; 7(7):e40484. PubMed ID: 22792348
[TBL] [Abstract][Full Text] [Related]
28. Homo-binding character of LMO2 isoforms and their both synergic and antagonistic functions in regulating hematopoietic-related target genes.
Sun W; Shen WW; Yang S; Hu F; Gao Y; Qiao YH; Zhu TH
J Biomed Sci; 2010 Mar; 17(1):22. PubMed ID: 20346173
[TBL] [Abstract][Full Text] [Related]
29. A novel transcript of the LMO2 gene, LMO2-c, is regulated by GATA-1 and PU.1 and encodes an antagonist of LMO2.
Wang Q; Zhang M; Wang X; Yuan W; Chen D; Royer-Pokora B; Zhu T
Leukemia; 2007 May; 21(5):1015-25. PubMed ID: 17361224
[TBL] [Abstract][Full Text] [Related]
30. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
[TBL] [Abstract][Full Text] [Related]
31. Ets factors and a newly identified polymorphism regulate Fli1 promoter activity in lymphocytes.
Nowling TK; Fulton JD; Chike-Harris K; Gilkeson GS
Mol Immunol; 2008 Jan; 45(1):1-12. PubMed ID: 17606295
[TBL] [Abstract][Full Text] [Related]
32. Gene transcription of fgl2 in endothelial cells is controlled by Ets-1 and Oct-1 and requires the presence of both Sp1 and Sp3.
Liu M; Leibowitz JL; Clark DA; Mendicino M; Ning Q; Ding JW; D'Abreo C; Fung L; Marsden PA; Levy GA
Eur J Biochem; 2003 May; 270(10):2274-86. PubMed ID: 12752447
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional regulation of CD1D1 by Ets family transcription factors.
Geng Y; Laslo P; Barton K; Wang CR
J Immunol; 2005 Jul; 175(2):1022-9. PubMed ID: 16002702
[TBL] [Abstract][Full Text] [Related]
34. Spi-1/PU.1 is a positive regulator of the Fli-1 gene involved in inhibition of erythroid differentiation in friend erythroleukemic cell lines.
Starck J; Doubeikovski A; Sarrazin S; Gonnet C; Rao G; Skoultchi A; Godet J; Dusanter-Fourt I; Morle F
Mol Cell Biol; 1999 Jan; 19(1):121-35. PubMed ID: 9858537
[TBL] [Abstract][Full Text] [Related]
35. The SCL complex regulates c-kit expression in hematopoietic cells through functional interaction with Sp1.
Lécuyer E; Herblot S; Saint-Denis M; Martin R; Begley CG; Porcher C; Orkin SH; Hoang T
Blood; 2002 Oct; 100(7):2430-40. PubMed ID: 12239153
[TBL] [Abstract][Full Text] [Related]
36. Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19).
Hirose K; Inukai T; Kikuchi J; Furukawa Y; Ikawa T; Kawamoto H; Oram SH; Göttgens B; Kiyokawa N; Miyagawa Y; Okita H; Akahane K; Zhang X; Kuroda I; Honna H; Kagami K; Goi K; Kurosawa H; Look AT; Matsui H; Inaba T; Sugita K
Blood; 2010 Aug; 116(6):962-70. PubMed ID: 20519628
[TBL] [Abstract][Full Text] [Related]
37. Role of ets factors in the activity and endothelial cell specificity of the mouse Tie gene promoter.
Iljin K; Dube A; Kontusaari S; Korhonen J; Lahtinen I; Oettgen P; Alitalo K
FASEB J; 1999 Feb; 13(2):377-86. PubMed ID: 9973326
[TBL] [Abstract][Full Text] [Related]
38. Human CD94 gene expression: dual promoters differing in responsiveness to IL-2 or IL-15.
Lieto LD; Borrego F; You CH; Coligan JE
J Immunol; 2003 Nov; 171(10):5277-86. PubMed ID: 14607929
[TBL] [Abstract][Full Text] [Related]
39. Identification of an enhancer of the human activating protein-2alpha gene that contains a critical Ets1 binding site.
Cheng YH; Handwerger S
J Clin Endocrinol Metab; 2003 Jul; 88(7):3305-11. PubMed ID: 12843180
[TBL] [Abstract][Full Text] [Related]
40. The Ets family contains transcriptional activators and repressors involved in angiogenesis.
Lelièvre E; Lionneton F; Soncin F; Vandenbunder B
Int J Biochem Cell Biol; 2001 Apr; 33(4):391-407. PubMed ID: 11312108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
